Review





Similar Products

96
Cell Signaling Technology Inc anti cleaved caspase 8
Anti Cleaved Caspase 8, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cleaved caspase 8/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
anti cleaved caspase 8 - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology caspase 8
Zn-SaCDs@Ap inhibits tumor growth and promotes necroptosis in tumor tissues. (A) Schematic diagram of the process of treating animal models with transplanted tumors and liver in situ tumors using Zn-SaCDs@Ap. (B) Live animal imaging of transplanted tumors. (C) Fluorescence live imaging of liver in situ tumors. (D) Statistics of fluorescence intensity of transplanted tumors. (E) Statistics of tumor size of transplanted tumors. (F) Statistics of fluorescence intensity of liver in situ tumors. (G) Immunofluorescence analysis revealed that the localization of Zn-SaCDs@Ap within tissue sections overlapped with areas of tumor necrosis. GPC3 and AFP, two well-established markers for hepatocellular carcinoma malignancy, were used to verify the aggressive nature of the tumor tissue. (H) HE staining of tumor tissues from transplanted tumors. Quantification of tumor necroptosis area in mice with transplanted tumors. (I) HE staining of tumors from liver in situ tumor mice. Quantification of tumor necroptosis area in liver in situ tumor mice. (J) IHC of necroptosis-related markers in liver in situ tumor mice. And the IHC score of necroptosis-related markers in liver in situ tumor mice. (K) IHC for proliferation marker Ki67 and apoptosis-related marker <t>cleaved</t> <t>caspase-8</t> (Casp8) in tumor tissues. (L) Statistics of fluorescence intensity of apoptosis and proliferation-related markers in liver in situ tumor mice. N = 6 biologically independent animals. Statistical analysis was analyzed by one-way/two-way ANOVA. ∗P < 0.05, ∗∗P < 0.01, n. s. = not significant.
Caspase 8, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/caspase 8/product/Santa Cruz Biotechnology
Average 96 stars, based on 1 article reviews
caspase 8 - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

96
Proteintech caspase 8 polyclonal antibody
Zn-SaCDs@Ap inhibits tumor growth and promotes necroptosis in tumor tissues. (A) Schematic diagram of the process of treating animal models with transplanted tumors and liver in situ tumors using Zn-SaCDs@Ap. (B) Live animal imaging of transplanted tumors. (C) Fluorescence live imaging of liver in situ tumors. (D) Statistics of fluorescence intensity of transplanted tumors. (E) Statistics of tumor size of transplanted tumors. (F) Statistics of fluorescence intensity of liver in situ tumors. (G) Immunofluorescence analysis revealed that the localization of Zn-SaCDs@Ap within tissue sections overlapped with areas of tumor necrosis. GPC3 and AFP, two well-established markers for hepatocellular carcinoma malignancy, were used to verify the aggressive nature of the tumor tissue. (H) HE staining of tumor tissues from transplanted tumors. Quantification of tumor necroptosis area in mice with transplanted tumors. (I) HE staining of tumors from liver in situ tumor mice. Quantification of tumor necroptosis area in liver in situ tumor mice. (J) IHC of necroptosis-related markers in liver in situ tumor mice. And the IHC score of necroptosis-related markers in liver in situ tumor mice. (K) IHC for proliferation marker Ki67 and apoptosis-related marker <t>cleaved</t> <t>caspase-8</t> (Casp8) in tumor tissues. (L) Statistics of fluorescence intensity of apoptosis and proliferation-related markers in liver in situ tumor mice. N = 6 biologically independent animals. Statistical analysis was analyzed by one-way/two-way ANOVA. ∗P < 0.05, ∗∗P < 0.01, n. s. = not significant.
Caspase 8 Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/caspase 8 polyclonal antibody/product/Proteintech
Average 96 stars, based on 1 article reviews
caspase 8 polyclonal antibody - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc clcaspase 8
Zn-SaCDs@Ap inhibits tumor growth and promotes necroptosis in tumor tissues. (A) Schematic diagram of the process of treating animal models with transplanted tumors and liver in situ tumors using Zn-SaCDs@Ap. (B) Live animal imaging of transplanted tumors. (C) Fluorescence live imaging of liver in situ tumors. (D) Statistics of fluorescence intensity of transplanted tumors. (E) Statistics of tumor size of transplanted tumors. (F) Statistics of fluorescence intensity of liver in situ tumors. (G) Immunofluorescence analysis revealed that the localization of Zn-SaCDs@Ap within tissue sections overlapped with areas of tumor necrosis. GPC3 and AFP, two well-established markers for hepatocellular carcinoma malignancy, were used to verify the aggressive nature of the tumor tissue. (H) HE staining of tumor tissues from transplanted tumors. Quantification of tumor necroptosis area in mice with transplanted tumors. (I) HE staining of tumors from liver in situ tumor mice. Quantification of tumor necroptosis area in liver in situ tumor mice. (J) IHC of necroptosis-related markers in liver in situ tumor mice. And the IHC score of necroptosis-related markers in liver in situ tumor mice. (K) IHC for proliferation marker Ki67 and apoptosis-related marker <t>cleaved</t> <t>caspase-8</t> (Casp8) in tumor tissues. (L) Statistics of fluorescence intensity of apoptosis and proliferation-related markers in liver in situ tumor mice. N = 6 biologically independent animals. Statistical analysis was analyzed by one-way/two-way ANOVA. ∗P < 0.05, ∗∗P < 0.01, n. s. = not significant.
Clcaspase 8, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clcaspase 8/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
clcaspase 8 - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

95
Proteintech caspase 8 antibody
Zn-SaCDs@Ap inhibits tumor growth and promotes necroptosis in tumor tissues. (A) Schematic diagram of the process of treating animal models with transplanted tumors and liver in situ tumors using Zn-SaCDs@Ap. (B) Live animal imaging of transplanted tumors. (C) Fluorescence live imaging of liver in situ tumors. (D) Statistics of fluorescence intensity of transplanted tumors. (E) Statistics of tumor size of transplanted tumors. (F) Statistics of fluorescence intensity of liver in situ tumors. (G) Immunofluorescence analysis revealed that the localization of Zn-SaCDs@Ap within tissue sections overlapped with areas of tumor necrosis. GPC3 and AFP, two well-established markers for hepatocellular carcinoma malignancy, were used to verify the aggressive nature of the tumor tissue. (H) HE staining of tumor tissues from transplanted tumors. Quantification of tumor necroptosis area in mice with transplanted tumors. (I) HE staining of tumors from liver in situ tumor mice. Quantification of tumor necroptosis area in liver in situ tumor mice. (J) IHC of necroptosis-related markers in liver in situ tumor mice. And the IHC score of necroptosis-related markers in liver in situ tumor mice. (K) IHC for proliferation marker Ki67 and apoptosis-related marker <t>cleaved</t> <t>caspase-8</t> (Casp8) in tumor tissues. (L) Statistics of fluorescence intensity of apoptosis and proliferation-related markers in liver in situ tumor mice. N = 6 biologically independent animals. Statistical analysis was analyzed by one-way/two-way ANOVA. ∗P < 0.05, ∗∗P < 0.01, n. s. = not significant.
Caspase 8 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/caspase 8 antibody/product/Proteintech
Average 95 stars, based on 1 article reviews
caspase 8 antibody - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc caspase 8
Zn-SaCDs@Ap inhibits tumor growth and promotes necroptosis in tumor tissues. (A) Schematic diagram of the process of treating animal models with transplanted tumors and liver in situ tumors using Zn-SaCDs@Ap. (B) Live animal imaging of transplanted tumors. (C) Fluorescence live imaging of liver in situ tumors. (D) Statistics of fluorescence intensity of transplanted tumors. (E) Statistics of tumor size of transplanted tumors. (F) Statistics of fluorescence intensity of liver in situ tumors. (G) Immunofluorescence analysis revealed that the localization of Zn-SaCDs@Ap within tissue sections overlapped with areas of tumor necrosis. GPC3 and AFP, two well-established markers for hepatocellular carcinoma malignancy, were used to verify the aggressive nature of the tumor tissue. (H) HE staining of tumor tissues from transplanted tumors. Quantification of tumor necroptosis area in mice with transplanted tumors. (I) HE staining of tumors from liver in situ tumor mice. Quantification of tumor necroptosis area in liver in situ tumor mice. (J) IHC of necroptosis-related markers in liver in situ tumor mice. And the IHC score of necroptosis-related markers in liver in situ tumor mice. (K) IHC for proliferation marker Ki67 and apoptosis-related marker <t>cleaved</t> <t>caspase-8</t> (Casp8) in tumor tissues. (L) Statistics of fluorescence intensity of apoptosis and proliferation-related markers in liver in situ tumor mice. N = 6 biologically independent animals. Statistical analysis was analyzed by one-way/two-way ANOVA. ∗P < 0.05, ∗∗P < 0.01, n. s. = not significant.
Caspase 8, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/caspase 8/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
caspase 8 - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

96
Proteintech antibodies casepase 8
Zn-SaCDs@Ap inhibits tumor growth and promotes necroptosis in tumor tissues. (A) Schematic diagram of the process of treating animal models with transplanted tumors and liver in situ tumors using Zn-SaCDs@Ap. (B) Live animal imaging of transplanted tumors. (C) Fluorescence live imaging of liver in situ tumors. (D) Statistics of fluorescence intensity of transplanted tumors. (E) Statistics of tumor size of transplanted tumors. (F) Statistics of fluorescence intensity of liver in situ tumors. (G) Immunofluorescence analysis revealed that the localization of Zn-SaCDs@Ap within tissue sections overlapped with areas of tumor necrosis. GPC3 and AFP, two well-established markers for hepatocellular carcinoma malignancy, were used to verify the aggressive nature of the tumor tissue. (H) HE staining of tumor tissues from transplanted tumors. Quantification of tumor necroptosis area in mice with transplanted tumors. (I) HE staining of tumors from liver in situ tumor mice. Quantification of tumor necroptosis area in liver in situ tumor mice. (J) IHC of necroptosis-related markers in liver in situ tumor mice. And the IHC score of necroptosis-related markers in liver in situ tumor mice. (K) IHC for proliferation marker Ki67 and apoptosis-related marker <t>cleaved</t> <t>caspase-8</t> (Casp8) in tumor tissues. (L) Statistics of fluorescence intensity of apoptosis and proliferation-related markers in liver in situ tumor mice. N = 6 biologically independent animals. Statistical analysis was analyzed by one-way/two-way ANOVA. ∗P < 0.05, ∗∗P < 0.01, n. s. = not significant.
Antibodies Casepase 8, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies casepase 8/product/Proteintech
Average 96 stars, based on 1 article reviews
antibodies casepase 8 - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

Image Search Results


Zn-SaCDs@Ap inhibits tumor growth and promotes necroptosis in tumor tissues. (A) Schematic diagram of the process of treating animal models with transplanted tumors and liver in situ tumors using Zn-SaCDs@Ap. (B) Live animal imaging of transplanted tumors. (C) Fluorescence live imaging of liver in situ tumors. (D) Statistics of fluorescence intensity of transplanted tumors. (E) Statistics of tumor size of transplanted tumors. (F) Statistics of fluorescence intensity of liver in situ tumors. (G) Immunofluorescence analysis revealed that the localization of Zn-SaCDs@Ap within tissue sections overlapped with areas of tumor necrosis. GPC3 and AFP, two well-established markers for hepatocellular carcinoma malignancy, were used to verify the aggressive nature of the tumor tissue. (H) HE staining of tumor tissues from transplanted tumors. Quantification of tumor necroptosis area in mice with transplanted tumors. (I) HE staining of tumors from liver in situ tumor mice. Quantification of tumor necroptosis area in liver in situ tumor mice. (J) IHC of necroptosis-related markers in liver in situ tumor mice. And the IHC score of necroptosis-related markers in liver in situ tumor mice. (K) IHC for proliferation marker Ki67 and apoptosis-related marker cleaved caspase-8 (Casp8) in tumor tissues. (L) Statistics of fluorescence intensity of apoptosis and proliferation-related markers in liver in situ tumor mice. N = 6 biologically independent animals. Statistical analysis was analyzed by one-way/two-way ANOVA. ∗P < 0.05, ∗∗P < 0.01, n. s. = not significant.

Journal: Materials Today Bio

Article Title: Apoptotic body-encapsulated zinc-doped Salvia miltiorrhiza carbon dots trigger PANoptosis for targeted therapy of hepatocellular carcinoma

doi: 10.1016/j.mtbio.2026.102984

Figure Lengend Snippet: Zn-SaCDs@Ap inhibits tumor growth and promotes necroptosis in tumor tissues. (A) Schematic diagram of the process of treating animal models with transplanted tumors and liver in situ tumors using Zn-SaCDs@Ap. (B) Live animal imaging of transplanted tumors. (C) Fluorescence live imaging of liver in situ tumors. (D) Statistics of fluorescence intensity of transplanted tumors. (E) Statistics of tumor size of transplanted tumors. (F) Statistics of fluorescence intensity of liver in situ tumors. (G) Immunofluorescence analysis revealed that the localization of Zn-SaCDs@Ap within tissue sections overlapped with areas of tumor necrosis. GPC3 and AFP, two well-established markers for hepatocellular carcinoma malignancy, were used to verify the aggressive nature of the tumor tissue. (H) HE staining of tumor tissues from transplanted tumors. Quantification of tumor necroptosis area in mice with transplanted tumors. (I) HE staining of tumors from liver in situ tumor mice. Quantification of tumor necroptosis area in liver in situ tumor mice. (J) IHC of necroptosis-related markers in liver in situ tumor mice. And the IHC score of necroptosis-related markers in liver in situ tumor mice. (K) IHC for proliferation marker Ki67 and apoptosis-related marker cleaved caspase-8 (Casp8) in tumor tissues. (L) Statistics of fluorescence intensity of apoptosis and proliferation-related markers in liver in situ tumor mice. N = 6 biologically independent animals. Statistical analysis was analyzed by one-way/two-way ANOVA. ∗P < 0.05, ∗∗P < 0.01, n. s. = not significant.

Article Snippet: After blocking, the membranes were incubated overnight at 4 °C with primary antibodies against Caspase-1 (Santa Cruz, USA), GSDMD (Zenbio, China), GSDME (Zenbio, China), Caspase-8 (Santa Cruz), Caspase-3 (Santa Cruz), Caspase-7 (Santa Cruz, USA), pMLKL (Zenbio, China), tMLKL (Zenbio, China), pRIPK3 (Zenbio, China), and tRIPK3 (Zenbio, China).

Techniques: In Situ, Imaging, Fluorescence, Immunofluorescence, Staining, Marker

Zn-SaCDs@Ap suppresses malignancy in HCC by inducing PANoptosis in tumors. (A) Schematic diagram of cell pyroptosis. (B) Expression of pyroptosis-related proteins caspase-1 (CASP1), GSDMD, and GSDME in Zn-SaCDs@Ap-treated Hep3B cells, as determined by Western blot analysis (C) IHC showing expression of pyroptosis markers in Zn-SaCDs@Ap treated in situ tumors. (D) Expression of pyroptosis markers in three cases of liver in situ tumors. (E) Schematic diagram of cell apoptosis. (F) Expression of apoptosis-related proteins caspase-3 (CASP3), caspase-8 (CASP8), and caspase-7 (CASP7) in Hep3B cells. (G) IHC showing expression of apoptosis markers in liver in situ tumors. (H) Expression of apoptosis markers in three cases of liver in situ tumors. (I) Schematic diagram of cell necroptosis. (J) Expression of necroptosis markers in Hep3B cells. (K) IHC showing expression of necroptosis markers in liver in situ tumors. (L) Expression of necroptosis markers in three cases of liver in situ tumors. (M) Multicolor immunofluorescence data demonstrate that Zn-SaCDs@Ap concurrently induces apoptosis, pyroptosis, and necroptosis. N = 6 biologically independent animals.

Journal: Materials Today Bio

Article Title: Apoptotic body-encapsulated zinc-doped Salvia miltiorrhiza carbon dots trigger PANoptosis for targeted therapy of hepatocellular carcinoma

doi: 10.1016/j.mtbio.2026.102984

Figure Lengend Snippet: Zn-SaCDs@Ap suppresses malignancy in HCC by inducing PANoptosis in tumors. (A) Schematic diagram of cell pyroptosis. (B) Expression of pyroptosis-related proteins caspase-1 (CASP1), GSDMD, and GSDME in Zn-SaCDs@Ap-treated Hep3B cells, as determined by Western blot analysis (C) IHC showing expression of pyroptosis markers in Zn-SaCDs@Ap treated in situ tumors. (D) Expression of pyroptosis markers in three cases of liver in situ tumors. (E) Schematic diagram of cell apoptosis. (F) Expression of apoptosis-related proteins caspase-3 (CASP3), caspase-8 (CASP8), and caspase-7 (CASP7) in Hep3B cells. (G) IHC showing expression of apoptosis markers in liver in situ tumors. (H) Expression of apoptosis markers in three cases of liver in situ tumors. (I) Schematic diagram of cell necroptosis. (J) Expression of necroptosis markers in Hep3B cells. (K) IHC showing expression of necroptosis markers in liver in situ tumors. (L) Expression of necroptosis markers in three cases of liver in situ tumors. (M) Multicolor immunofluorescence data demonstrate that Zn-SaCDs@Ap concurrently induces apoptosis, pyroptosis, and necroptosis. N = 6 biologically independent animals.

Article Snippet: After blocking, the membranes were incubated overnight at 4 °C with primary antibodies against Caspase-1 (Santa Cruz, USA), GSDMD (Zenbio, China), GSDME (Zenbio, China), Caspase-8 (Santa Cruz), Caspase-3 (Santa Cruz), Caspase-7 (Santa Cruz, USA), pMLKL (Zenbio, China), tMLKL (Zenbio, China), pRIPK3 (Zenbio, China), and tRIPK3 (Zenbio, China).

Techniques: Expressing, Western Blot, In Situ, Immunofluorescence